NodeAI featured in Hospital News

Hospital News covers the clinical trial now underway at Toronto General Hospital to validate NodeAI's real-time AI platform for EBUS-TBNA lung cancer staging. The article explains how the technology predicts lymph node malignancy during the procedure, with the goal of reducing inconclusive results and operator-to-operator variability. Read the full article here.

Previous
Previous

NodeAI featured in Canadian Healthcare Technology

Next
Next

NodeAI Selected for Ontario's $5 Million Life Sciences Innovation Fund.